1-3 of 3
Pieter Van lierberghe
Close
Sort by
Journal Articles

Identification of a Novel T-ALL Entity with NKX2-1/NKX2-2 Rearrangements

Irene Homminga, Rob Pieters, MD, PhD, Anton Langerak, PhD, Johan de Rooi, Andrew Stubbs, PhD, Monique Verstegen, PhD, Maartje Vuerhard, Jessica Buijs-Gladdines, Clarissa Kooi, Petra Klous, Pieter Van lierberghe, PhD, Adolfo Ferrando, MD, PhD, Jean-Michel Cayuela, MD, PhD, Brenda Verhaaf, Berna Beverloo, PhD, Martin A. Horstmann, MD, Valerie de Haas, MD, PhD, Anna-Sophia Wiekmeijer, Karin Pike-Overzet, PhD, Frank Staal, PhD, Wouter de Laat, PhD, Jean Soulier, MD, PhD, Francois Sigaux, MD, PhD, Jules P.P. Meijerink, PhD
Journal: Blood
Blood (2010) 116 (21): 3139.
https://doi.org/10.1182/blood.V116.21.3139.3139
Published: 2010
Journal Articles

High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial

Jay P. Patel, Omar Abdel-Wahab, Mithat Gonen, Maria E. Figueroa, MD, Hugo F. Fernandez, MD, Zhuoxin Sun, PhD, Janis Racevskis, Pieter Van lierberghe, Igor Dolgalev, Janice Cheng, Agnes Viale, Nicholas Socci, Adriana Heguy, Rhett Ketterling, Robert E. Gallagher, MD, Mark R. Litzow, MD, Jacob M. Rowe, Adolfo Ferrando, MD, PhD, Elisabeth Paietta, PhD, Martin S. Tallman, MD, Ari M. Melnick, Ross Levine, MD
Journal: Blood
Blood (2010) 116 (21): 851.
https://doi.org/10.1182/blood.V116.21.851.851
Published: 2010
Journal Articles

MEF2C as Novel Oncogene for Early T-Cell Precursor (ETP) Leukemia

Irene Homminga, Rob Pieters, MD, PhD, Anton Langerak, Johan de Rooi, Andrew Stubbs, PhD, Monique Verstegen, Maartje Vuerhard, Jessica Buijs-Gladdines, Clarissa Kooi, Petra Klous, Pieter Van lierberghe, Adolfo Ferrando, Jean-Michel Cayuela, MD, PhD, Brenda Verhaaf, Berna Beverloo, Martin A. Horstmann, MD, Valerie de Haas, Anna-Sophia Wiekmeijer, Karin Pike-Overzet, Frank Staal, Wouter de Laat, Jean Soulier, MD, PhD, Francois Sigaux, Jules Meijerink
Journal: Blood
Blood (2010) 116 (21): 9.
https://doi.org/10.1182/blood.V116.21.9.9
Published: 2010